Spondyloarthritis & psoriatic arthritis

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis

RMD OpenPublished Prospective cohort study

Authors' conclusion

Serum levels of LBP and calprotectin are associated with disease activity in patients with r-axSpA and decrease with TNFi response. In contrast, serum zonulin levels showed no association with disease activity or treatment response, arguing against a strict correlation between intestinal permeability and disease activity in axSpA.

Study context

Population
Patients with active radiographic axial spondyloarthritis (r-axSpA) of the German Spondyloarthritis Inception Cohort starting tumour necrosis factor inhibitor (TNFi), and controls with chronic back pain
Participants
121 vs 63
Exposure
r-axSpA patients starting TNFi vs controls with chronic back pain
  • r-axSpAn = 121
  • Controlsn = 63reference
Outcome
Serum LBP, zonulin and calprotectin levels and their association with disease activity and treatment response
Follow-up
Baseline and after 1 year of TNFi therapy
Methodological detailslongitudinal, regression analysis, German Spondyloarthritis Inception Cohort
  • Longitudinal
  • Regression analysis
  • German Spondyloarthritis Inception Cohort

Main finding

As reported in the abstract

Lipopolysaccharid-binding protein (LBP) association with ASDAS, longitudinal (ß)
0.08 (95% CI 0.06 to 0.10)
LBP association with Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), longitudinal (ß)
0.08 (95% CI 0.04 to 0.12)
LBP association with C reactive protein (CRP), longitudinal (ß)
1.69 (95% CI 1.04 to 2.34)
Calprotectin association with ASDAS (ß)
0.04 (95% CI 0.01 to 0.07)
Calprotectin association with CRP (ß)
0.82 (95% CI 0.27 to 1.37)

Observational data: associations, not effects.

Original publication

Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis. RMD Open. Published 31 December 2024. doi:10.1136/rmdopen-2024-004752

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.